Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF: Cell
IJMS | Free Full-Text | BRAF-Mutated Colorectal Cancer: Clinical and Molecular Insights
Cancers | Free Full-Text | BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
BRAF mutant colorectal cancer as a distinct subset of colorectal cancer: clinical characteristics, clinical behavior, and response to targeted therapies. | Semantic Scholar
Cancers | Free Full-Text | BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
BRAF Mutation in Colorectal Cancer | IntechOpen
Evolving Strategies for the Management of BRAF-Mutant Metastatic Colorectal Cancer
Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan | BMC Cancer | Full Text
Promising Strategies for Overcoming BRAF Inhibitor Resistance Based on Known Resistance Mechanisms | Bentham Science
How the BRAF V600E Mutation Defines a Distinct Subgroup of Colorectal Cancer: Molecular and Clinical Implications
BRAF Biomarker | Colorectal Cancer Alliance
KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer - The Lancet Oncology
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer | Cancer Cell International | Full Text
BRAF-Mutated Advanced Colorectal Cancer: A Rapidly Changing Therapeutic Landscape | Journal of Clinical Oncology
Exploring the best treatment options for BRAF-mutant metastatic colon cancer | British Journal of Cancer
Personalized Medicine in Oncology - <em>BRAF</em> Mutation in Colorectal Cancer<br> <h4>Anita Turk, MD; Dustin Deming, MD<br>Division of Hematology and Oncology,Department of Medicine<br>University of Wisconsin-Madison School of Medicine and Public ...
Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines - Annals of Oncology
Triple Inhibition May Cripple BRAF-Mutated Colorectal Cancer - The ASCO Post
Frontiers | Management of BRAF Gene Alterations in Metastatic Colorectal Cancer: From Current Therapeutic Strategies to Future Perspectives
Targeted Drug Trio for Colorectal Cancer with BRAF Mutations - NCI
New combination therapy offers bowel cancer patients extra treatment option
Acquired resistance to target therapies in BRAF mutant colorectal cancer | Download Scientific Diagram
Toward a Molecular Classification of Colorectal Cancer: The Role of BRAF. - Abstract - Europe PMC
